Lithium + Amphetamines #78
Replies: 3 comments 2 replies
-
Looking at these studies, it seems to agree and support what you have said. However, I'm hesitant to push this to an issue as I'm personally not exactly sure what all of the studies are saying for this. |
Beta Was this translation helpful? Give feedback.
-
Lithium may be neuroprotective when taken with amphetamines and Lithium may decrease the hyperactive effects of amphetamines. Studies indicate this combination is safe. Ago, Y., Tanaka, T., Kita, Y., Tokumoto, H., Takuma, K., & Matsuda, T. (2012). Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release. Neuropharmacology, 62(4), 1634–1639. https://doi.org/10.1016/j.neuropharm.2011.10.004 Gould, T. D., O’Donnell, K. C., Picchini, A. M., & Manji, H. K. (2007). Strain Differences in Lithium Attenuation of d-Amphetamine-Induced Hyperlocomotion: A Mouse Model for the Genetics of Clinical Response to Lithium. Neuropsychopharmacology, 32(6), 1321–1333. https://doi.org/10.1038/sj.npp.1301254 Zhou, Z., Wang, Y., Tan, H., Bharti, V., Che, Y., & Wang, J.-F. (2015). Chronic treatment with mood stabilizer lithium inhibits amphetamine-induced risk-taking manic-like behaviors. Neuroscience Letters, 603, 84–88. https://doi.org/10.1016/j.neulet.2015.07.027 Silverstone, P. H., Pukhovsky, A., & Rotzinger, S. (1998). Lithium does not attenuate the effects of d-amphetamine in healthy volunteers. Psychiatry Research, 79(3), 219–226. https://doi.org/10.1016/S0165-1781(98)00037-7 |
Beta Was this translation helpful? Give feedback.
-
Pushed 🥳 |
Beta Was this translation helpful? Give feedback.
-
Rodent and human studies indicate that this combination is safe and that lithium may be neuroprotective when taken with amphetamines and that lithium can decrease the hyperactive effects.
Ago, Y., Tanaka, T., Kita, Y., Tokumoto, H., Takuma, K., & Matsuda, T. (2012). Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release. Neuropharmacology, 62(4), 1634–1639. https://doi.org/10.1016/j.neuropharm.2011.10.004
Gould, T. D., O’Donnell, K. C., Picchini, A. M., & Manji, H. K. (2007). Strain Differences in Lithium Attenuation of d-Amphetamine-Induced Hyperlocomotion: A Mouse Model for the Genetics of Clinical Response to Lithium. Neuropsychopharmacology, 32(6), 1321–1333. https://doi.org/10.1038/sj.npp.1301254
Zhou, Z., Wang, Y., Tan, H., Bharti, V., Che, Y., & Wang, J.-F. (2015). Chronic treatment with mood stabilizer lithium inhibits amphetamine-induced risk-taking manic-like behaviors. Neuroscience Letters, 603, 84–88. https://doi.org/10.1016/j.neulet.2015.07.027
Beta Was this translation helpful? Give feedback.
All reactions